recent post

Counterfeit drugs remain a challenge for pharma companies-Suresh Subramanian, National Lifesciences Leader, EY Parthenon India

December 5, 2024
recent post

Automation in Action: How Tech is Revolutionising Clinical Diagnostics in India

recent post

Bajaj Finserv AMC launches Bajaj Finserv Healthcare Fund

recent post

ENTOD Pharmaceuticals ropes in Dr Anish Desai as Scientific & Research AdviserĀ 

recent post

LPU's International Conference of Pharmacy 2024 discuss ways to transform pharma landscape

Anubhav Anusha, Founder, GeneStore and PathStore launch CoE for molecular diagnostics and proteomics

Anubhav Anusha, Founder, GeneStore and PathStore launch CoE for molecular diagnostics and proteomics

The launch will enable affordable diagnostics for infectious diseases in India GeneStore's Founder, Anubhav Anusha, announced the launch of the Company's Center of Excellence for Molecular Diagnostics and Proteomics in Gurugram, Haryana. The state-of-the-art research and manufacturing facility is dedicated to the development and manufacturing of RT-PCR kits for infectious diseases such as Tuberculosis, HIV, Dengue, Hepatitis C, Japanese Encephalitis Virus that contribute to a high public health burden in India. GeneStore's mission in India is to support the government in drastically lowering healthcare costs related to diagnostic testing for infectious diseases through its highly affordable RT-PCR testing kits. "We have a pipeline of RT-PCR diagnostic kits for over 80 infectious disease pathogens that are relevant across diverse regions across India and the world. GeneStore's model of affordability and high quality for RT-PCR diagnostic kits, which was perfected during the COVID-19 pandemic, will enable us to serve governments and NGO's across the world to better combat infectious diseases through affordability and innovation," said Anusha.